Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Related Articles
Rabin Medical Center Continues to Lead
For the first time in Israel, Rabin Medical Center's Department of Cardiothoracic Surgery, headed by Dr. Eyal Porat, implanted an artificial heart as a replacement for a real heart.
The Future is Here, for a Better Tomorrow
The Second International Advisory Board Meeting and Symposium of the Raphael Recanati Genetic Institute, chaired by Prof. Moshe Garty was recently held at Rabin Medical Center.
Radiologist Wins Prestigious Nash Foundation Grant
Dr. Gideon Shafir, senior radiologist at the Rabin Medical Center,
won a Nash Foundation grant for a visiting fellowship in cardiovascular
imaging at Stanford University.